000 01283 a2200349 4500
005 20250515094943.0
264 0 _c20071227
008 200712s 0 0 eng d
022 _a1756-1833
024 7 _a10.1136/bmj.39398.682500.25
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAfshari, Arash
245 0 0 _aAntithrombin III in critically ill patients: systematic review with meta-analysis and trial sequential analysis.
_h[electronic resource]
260 _bBMJ (Clinical research ed.)
_cDec 2007
300 _a1248-51 p.
_bdigital
500 _aPublication Type: Journal Article; Meta-Analysis; Review; Systematic Review
650 0 4 _aAnticoagulants
_xtherapeutic use
650 0 4 _aAntithrombin III
_xtherapeutic use
650 0 4 _aCritical Care
650 0 4 _aCritical Illness
_xmortality
650 0 4 _aHumans
650 0 4 _aLength of Stay
650 0 4 _aQuality of Life
650 0 4 _aRandomized Controlled Trials as Topic
650 0 4 _aRespiration, Artificial
650 0 4 _aRisk Factors
700 1 _aWetterslev, Jørn
700 1 _aBrok, Jesper
700 1 _aMøller, Ann
773 0 _tBMJ (Clinical research ed.)
_gvol. 335
_gno. 7632
_gp. 1248-51
856 4 0 _uhttps://doi.org/10.1136/bmj.39398.682500.25
_zAvailable from publisher's website
999 _c17552976
_d17552976